{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:21:16Z","timestamp":1785550876145,"version":"3.56.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ygyno.2013.12.014","type":"journal-article","created":{"date-parts":[[2013,12,16]],"date-time":"2013-12-16T21:49:23Z","timestamp":1387230563000},"page":"428-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Risk management options elected by women after testing positive for a BRCA mutation"],"prefix":"10.1016","volume":"132","author":[{"given":"Christine","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Wendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramey D.","family":"Littell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Anne","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Raine-Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Bethan","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.12.014_bb0010","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome","volume":"113","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.12.014_bb0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","article-title":"Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"7","author":"Domchek","year":"2006","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ygyno.2013.12.014_bb0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2013.12.014_bb0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/gtmb.2008.0067","article-title":"Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers","volume":"13","author":"Beattie","year":"2009","journal-title":"Genet Test Mol Biomarkers"},{"issue":"2","key":"10.1016\/j.ygyno.2013.12.014_bb0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/2013.jamainternmed.962","article-title":"Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing","volume":"173","author":"Mannis","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.ygyno.2013.12.014_bb0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3816\/CBC.2007.n.053","article-title":"Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers","volume":"7","author":"Friebel","year":"2007","journal-title":"Clin Breast Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2013.12.014_bb0040","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.12.014_bb0045","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/cncr.26294","article-title":"Long-term outcomes of BRCA1\/BRCA2 testing: risk reduction and surveillance","volume":"118","author":"Schwartz","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.12.014_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00404-010-1476-3","article-title":"Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers","volume":"283","author":"Rhiem","year":"2011","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"10.1016\/j.ygyno.2013.12.014_bb0055","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1200\/JCO.2007.12.6078","article-title":"Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the hereditary breast cancer clinical study group","volume":"26","author":"Metcalfe","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.12.014_bb0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajmg.a.10102","article-title":"Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2years post testing","volume":"118A","author":"Botkin","year":"2003","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ygyno.2013.12.014_bb0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.a.20431","article-title":"Screening adherence in BRCA1\/2 families is associated with primary physicians' behavior","volume":"125A","author":"Tinley","year":"2004","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.ygyno.2013.12.014_bb0070","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1188\/09.ONF.E57-E67","article-title":"Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing","volume":"36","author":"Loescher","year":"2009","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.ygyno.2013.12.014_bb0075","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","article-title":"Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)","volume":"365","author":"Leach","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ygyno.2013.12.014_bb0080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10549-011-1449-7","article-title":"Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers","volume":"129","author":"Dhar","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"25","key":"10.1016\/j.ygyno.2013.12.014_bb0085","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1200\/JCO.2007.11.1179","article-title":"Oral contraceptives and breast cancer risk in the international BRCA1\/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group","volume":"25","author":"Brohet","year":"2007","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.ygyno.2013.12.014_bb0090","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","article-title":"Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"94","author":"Narod","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.ygyno.2013.12.014_bb0095","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/aje\/kwh284","article-title":"Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations","volume":"160","author":"McGuire","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"31","key":"10.1016\/j.ygyno.2013.12.014_bb0100","doi-asserted-by":"crossref","first-page":"7772","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE study group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.ygyno.2013.12.014_bb0105","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/jnci\/djn313","article-title":"Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers","volume":"100","author":"Eisen","year":"2008","journal-title":"J Natl Cancer Inst"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813013784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813013784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T05:26:43Z","timestamp":1538976403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813013784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0090825813013784"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk management options elected by women after testing positive for a BRCA mutation","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}